Literature DB >> 23105635

Defect in mitochondrial functions in damaged human mitral valve.

Santosh Shinde1, Pawan Kumar, Kaushala Mishra, Neela Patil.   

Abstract

Mitochondrial diseases are a heterogeneous group of disorders in which a primary mitochondrial dysfunction is proven by morphological, biochemical, and genetic examinations. The mitral valve has important function in the regulation of blood flow from one chamber to another. Often, the mitral valve becomes abnormal with age, in Rheumatic fever or it is abnormal from birth (Congenital) or it can be destroyed by infection i.e. bacterial endocarditis and needs replacement. Myocardial function depends on energy produced by mitochondria and in any of these disease conditions, mitochondrial functions and enzyme activities may be impaired. With this in view, we analyzed the relationship between preoperative clinical conditions (as per New York heart Association) and extent of mitochondrial enzyme activities in damaged Human mitral valve in two types of heart disease such as Rheumatic Heart Disease (RHD) and Bacterial Endocarditis (BE). Thirty nine Patients undergoing cardiopulmonary bypass (CPB) for routine valvular heart surgery were included in the study. Controls included 11 normal porcine mitral valve samples without any evidence of heart disease. Mitochondrial enzymes like cytochrome oxidase (COX), succinate dehydrogenase (SDH), malate dehydrogenase (MDH), citrate synthase (CS) and ATPase were determined. Mitochondrial COX, SDH, CS and Total ATPase activities were significantly decreased in disease condition like BE and RHD when compared with control (P<0.001). On the other hand as per New York Heart Association (NYHA) preoperative clinical classification, all the mitochondrial enzymes were significantly (p<0.05) impaired in class IV as compared with NYHA class I, II and III. Present study shows that impairment in the mitochondrial enzymes activities are more pronounced in bacterial endocarditis (BE). It also indicates that damage to mitochondrial enzymes are most pronounced in NYHA class IV.

Entities:  

Keywords:  Human heart; Mital valve; and Mitochondrial functions

Year:  2006        PMID: 23105635      PMCID: PMC3453995          DOI: 10.1007/BF02912933

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  17 in total

1.  Mitochondrial function, oxygen extraction, epicardial S-T segment changes and tritiated digoxin distribution after reperfusion of ischemic myocardium.

Authors:  J J Kane; M L Murphy; J K Bissett; N deSoyza; J E Doherty; K D Straub
Journal:  Am J Cardiol       Date:  1975-08       Impact factor: 2.778

2.  PROSTHETIC REPLACEMENT OF THE MITRAL VALVE. OPERATIVE METHODS AND THE RESULTS OF PREOPERATIVE AND POSTOPERATIVE HEMODYNAMIC ASSESSMENTS.

Authors:  A G MORROW; W D CLARK; D C HARRISON; E BRAUNWALD
Journal:  Circulation       Date:  1964-04       Impact factor: 29.690

3.  Some metabolic characteristics of mitochondria from chronically overloaded, hypertrophied hearts.

Authors:  A WOLLENBERGER; B KLEITKE; G RAABE
Journal:  Exp Mol Pathol       Date:  1963-06       Impact factor: 3.362

4.  Differences in efficiency of energy transfer in mitochondrial systems derived from normal and failing hearts.

Authors:  M M GERTLER
Journal:  Proc Soc Exp Biol Med       Date:  1961-01

5.  Spectrophotometric assay of cytochrome c oxidase.

Authors:  L SMITH
Journal:  Methods Biochem Anal       Date:  1955

6.  Mechanisms of synthesis of adenosine triphosphate.

Authors:  E RACKER
Journal:  Adv Enzymol Relat Subj Biochem       Date:  1961

7.  [Cytochrome system of myocardial mitochondria in patients with mitral valve insufficiency].

Authors:  V I Maliuk; A A Tsyganiĭ; N A Medvinskaia
Journal:  Kardiologiia       Date:  1976-05       Impact factor: 0.395

8.  [Cytochrome C in diphtheric intoxication].

Authors:  I Viti
Journal:  Pathologica       Date:  1968 May-Jun

9.  Oxidative stress in atherosclerosis-prone mouse is due to low antioxidant capacity of mitochondria.

Authors:  Helena C F Oliveira; Ricardo G Cosso; Luciane C Alberici; Evelise N Maciel; Alessandro G Salerno; Gabriel G Dorighello; Jesus A Velho; Eliana C de Faria; Aníbal E Vercesi
Journal:  FASEB J       Date:  2004-11-29       Impact factor: 5.191

10.  Developmental changes of cytochrome c oxidase and citrate synthase in rat heart homogenate.

Authors:  Z Drahota; M Milerová; A Stieglerová; J Houstek; B Ostádal
Journal:  Physiol Res       Date:  2004       Impact factor: 1.881

View more
  2 in total

Review 1.  Metabolic enzymes dysregulation in heart failure: the prospective therapy.

Authors:  Priyanka Parihar; Mordhwaj Singh Parihar
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

Review 2.  Aortic Valve Stenosis and Mitochondrial Dysfunctions: Clinical and Molecular Perspectives.

Authors:  Gaia Pedriali; Giampaolo Morciano; Simone Patergnani; Paolo Cimaglia; Cristina Morelli; Elisa Mikus; Roberto Ferrari; Vincenzo Gasbarro; Carlotta Giorgi; Mariusz R Wieckowski; Paolo Pinton
Journal:  Int J Mol Sci       Date:  2020-07-11       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.